Spartalizumab
Spartalizumab is a monoclonal antibody from Novartis Pharmaceuticals, in registered phase 2 trials for myelodysplastic syndromes / neoplasms.
Overview
Spartalizumab is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Novartis Pharmaceuticals, in myelodysplastic syndromes / neoplasms. A monoclonal antibody: the international non-proprietary name stem -mab marks an antibody that binds one target. The registry record does not state the target unless named in the trial entries below. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
A monoclonal antibody: the international non-proprietary name stem -mab marks an antibody that binds one target. The registry record does not state the target unless named in the trial entries below.
1.Spartalizumab binds its target.
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"Spartalizumab" OR ABSTRACT:"Spartalizumab" OR TITLE:"PDR001" OR ABSTRACT:"PDR001") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Spartalizumab, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentSabatolimab
Shares Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab., Advanced Accelerator Applications (Novartis), Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TreatmentAMO959
Shares Advanced Accelerator Applications (Novartis) and the tags pipeline, registry-only.
- TreatmentARD103
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TreatmentTNO155
Shares Advanced Accelerator Applications (Novartis) and the tags pipeline, registry-only.
- TreatmentBexmarilimab
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TreatmentTuspetinib
Shares Myelodysplastic syndromes / neoplasms (MDS) and the tags pipeline, registry-only.
- TreatmentAdavosertib
Shares the tags pipeline, registry-only.
- TreatmentAlisertib
Shares the tags pipeline, registry-only.